MOLN CIK: 1745114

Molecular Partners AG ADR

  • Switzerland
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions CHF
FY21:
−91.0
FY22:
119
FY23:
−59.0
FY24:
−59.2
FY25:
−51.3
Change from FY21 to FY25
millions CHF
FY21:
−22.2
FY22:
−101
FY23:
44.6
FY24:
40.5
FY25:
72.5
Change from FY21 to FY25
millions CHF
FY21:
50.6
FY22:
−1.57
FY23:
−1.17
FY24:
14.4
FY25:
−1.15
millions CHF
FY21:
−61.9
FY22:
16.1
FY23:
−20.6
FY24:
−3.44
FY25:
18.8
(positive)
Change from FY21 to FY25
millions CHF
FY21:
−91.9
FY22:
117
FY23:
−59.6
FY24:
−60.0
FY25:
−52.0

All amounts in millions CHF Data source:SEC EDGAR